missing translation for 'onlineSavingsMsg'
Få mere at vide

Doxorubicin Hydrochloride, Fisher BioReagents

Produktkode p-25631
missing translation for 'orderingAttributeHoverText'
Quantity:
1 mg
5 mg
10 mg
50 mg
Packaging:
Amber Glass
Förpackningsstorlek
10mg
1mg
50mg
5mg
Denne vare kan ikke returneres. Se returpolitik
Regulatorisk: Dette produkt falder ind under Lov om kemiske stoffer og produkter - lovbekendtgørelse nr. 1755 af 22. december 2006. Hvis det er relevant, skal kunden fremskaffe en licens før levering.

Produktkode 10512955

missing translation for 'mfr': Fisher BioReagents BP25161

Request Bulk or Custom Format

Please to purchase this item. Need a web account? Register with us today!

This item is currently unavailable or has been discontinued.
View the product page for possible alternatives.
Se alternative produkter

Denne vare kan ikke returneres. Se returpolitik
Regulatorisk: Dette produkt falder ind under Lov om kemiske stoffer og produkter - lovbekendtgørelse nr. 1755 af 22. december 2006. Hvis det er relevant, skal kunden fremskaffe en licens før levering.

Doxorubicin Hydrochloride

Doxorubicin HCL is a chemotherapeutic agent. Antitumor, immunosuppressive, and antibiotic agent. It blocks RNA polymerase and reverse transcriptase. Also inhibits nucleic acid synthesis.
TRUSTED_SUSTAINABILITY

Kemiske identifikatorer

CAS 25316-40-9
Molecular Formula C27H30ClNO11
Molecular Weight (g/mol) 579.98
MDL Number MFCD00077757,MFCD00077757,MFCD00941448
InChI Key MWWSFMDVAYGXBV-FGBJBKNOSA-N
Synonym doxorubicin hydrochloride, adriamycin, doxorubicin hcl, adriacin, adriblastina, rubex, adriamycin hydrochloride, adriblastin, adriamycin pfs
PubChem CID 129626538
IUPAC Name (7R,9R)-7-[(2S,4R,5R,6R)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
SMILES [H+].[Cl-].COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3OC3CC(N)C(O)C(C)O3)C(=O)CO)C(O)=C1C2=O

Tekniske data

Decomposition Information 216°C
Melting Point 216°C
Color Orange
Assay Percent Range (by HPLC): ≥95%
Packaging Amber Glass
Quantity 1 mg
Merck Index 15, 3487
Solubility Information Soluble in water
Formula Weight 580
Physical Form Powder or Solid
Chemical Name or Material Doxorubicin Hydrochloride
Vis mere Vis mindre
compliance-icons compliance-icons compliance-icons
Produktidentifikator
  • Doxorubicin hydrochloride
Signalord
  • Danger
Farekategori
  • Acute toxicity Category 4
  • Carcinogenicity Category 1B
  • Serious eye damage/eye irritation Category 1
  • Germ cell mutagenicity Category 1B
  • Reproductive toxicity Category 2
  • Skin corrosion/irritation Category 2
  • Specific target organ toxicity Category 3
Faresætning
  • H318-Causes serious eye damage.
  • H340-May cause genetic defects.
  • H350-May cause cancer.
  • H315-Causes skin irritation.
  • H361fd-Suspected of damaging fertility. Suspected of damaging the unborn child.
  • H335-May cause respiratory irritation.
  • H302-Harmful if swallowed.
Sikkerhedssætning
  • P201-Obtain special instructions before use.
  • P280-Wear protective gloves/protective clothing/eye protection/face protection.
  • P303+P361+P353-IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/ shower.
  • P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
  • P310-Immediately call a POISON CENTER/doctor/.
Korrektion af produktindhold

Dit input er vigtigt for os. Udfyld denne formular for at give feedback relateret til indholdet på dette produkt.

Produkttitel

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.

Mange tak! Din feedback er blevet sendt. Hos Fisher Scientific arbejder vi altid på at forbedre vores indhold for dig. Vi sætter pris på din feedback.